Latest Molecular imaging Stories
SAN DIEGO, May 3, 2011 /PRNewswire/ -- Researchers from the University of Cincinnati presented results from a prospective study at the American Roentgen Ray Society 2011 Annual Meeting today, demonstrating how PEM-guided biopsy may expedite pre-operative work-up and reduce radiation exposure for breast cancer patients.
LOS ANGELES, April 18, 2011 /PRNewswire/ -- ImaginAb, Inc.
LOS ANGELES and KYOTO, Japan, April 11, 2011 /PRNewswire/ -- ImaginAb, Inc. and Dainippon Seiki Co., Ltd.
ORANGEBURG, N.Y. and VICTORIA, British Columbia, April 4, 2011 /PRNewswire/ -- Spectrum Dynamics announced today it has shipped and installed the second D-SPECT system using Cadmium Zinc Telluride (CZT) nuclear imaging modules from a new supplier, Redlen Technologies Inc.
CULVER CITY, Calif., April 4, 2011 /PRNewswire/ -- Sofie Biosciences, a developer of molecular imaging systems and agents, announced the launch of GENISYS4, their new benchtop small animal PET system.
LAS VEGAS, March 17, 2011 /PRNewswire/ -- A new study by Craig Thiessen, M.D., Director of Radiology for West Houston Radiology L.L.P.
VIENNA, March 2, 2011 /PRNewswire/ -- Naviscan, Inc., announces the European launch of the Naviscan Positron Emission Mammography (PEM) scanner at two prestigious radiology conferences in Vienna.
SAN DIEGO, Feb. 24, 2011 /PRNewswire/ -- Naviscan, Inc. announced that it has entered into an exclusive licensing agreement with Neoprobe Corporation (NYSE Amex: NEOP) as a partner to further develop its patented imaging technology.
Positron emission tomography (PET) can image metabolic changes following treatment with the protein kinase inhibitor vandetanib, helping to define the therapy response or the effectiveness of the therapeutic agent.
- A poem in which the author retracts something said in an earlier poem.